https://doi.org/10.1186/s12890-023-02360-4
F
Fangping Ding
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
8
Papers
51
Citations
4
h-index
2
i10-index
Fangping Ding is an academic researcher from Capital Medical University. The author has contributed to research in topics: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis & Liver Disease and Transplantation & Sphingolipid Metabolism and Signaling. The author has an h-index of 4, co-authored 7 publications.
Papers by this author
worksSerum Rcn3 level is a potential diagnostic biomarker for connective tissue disease-associated interstitial lung disease and reflects the severity of pulmonary function
2023 · BMC Pulmonary Medicine · 9 citations
Serum S1P level in interstitial lung disease (ILD) is a potential biomarker reflecting the severity of pulmonary function
2024 · BMC Pulmonary Medicine · 6 citations
https://doi.org/10.1186/s12890-024-03081-y
Increased pro-SFTPB in HDL promotes the pro-inflammatory transition of HDL and represents a sign of poor prognosis in ARDS patients
2025 · Journal of Translational Medicine · 2 citations
https://doi.org/10.1186/s12967-025-06100-6
Plasma Reticulocalbin 3 (RCN3) is a Novel Biomarker for the Early Diagnosis of Hepatopulmonary Syndrome in Cirrhotic Patients
2025 · Lung · 1 citations
https://doi.org/10.1007/s00408-025-00807-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat